-
4 College Degrees Jack Ma Says Will Be Valuable In The Future
Thursday, June 29, 2017 - 5:02pm | 574Read More...Alibaba Group Holding Ltd (NYSE: BABA) founder Jack Ma recently discussed the ways the world is changing and the implications for the global economy in an interview with CNBC. Over the next 30 years, technology will evolve in a way that will make millions of jobs obsolete. While the transition will...
-
Kite Pharma A Top Pick Ahead Of Axi-Cel Launch
Tuesday, June 27, 2017 - 8:27am | 548Read More...Kite Pharma Inc (NASDAQ: KITE) is preparing to launch Axi-Cel, a chimeric antigen receptor T-cell therapy for non-Hodgkin’s lymphoma patients, later this year. Kite is pursuing an FDA label for patients with relapsed, aggressive and non-transplant eligible forms of the disease, a group of...
-
Investing In The Future Means Investing In Robotics Software And Services
Monday, June 26, 2017 - 8:28am | 531Read More...Loup Ventures is siding with the machines, concluding on Friday a series of notes analyzing the growth of robotics in the economy. “We believe a cultural shift is underway and robots are playing an increasingly crucial role in our everyday lives,” said analyst Andrew Murphy. Murphy...
-
So What If Robots Replace Puny Humans? Pro Chides Google Chief's Rosy View Of Automation
Tuesday, June 20, 2017 - 9:32am | 541Read More...Doug Clinton of Loup Ventures says Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) Chairman Eric Schmidt is wrong when he says automation won’t wipe out the majority of jobs now performed by inferior humans. “The five-year picture of automation isn’t going to result in mass job loss,...
-
For Rare Neural Diseases, Is Ovid Therapeutics The Right Team At The Right Time?
Tuesday, May 30, 2017 - 2:17pm | 390Read More...The Cowen Group has initiated coverage on Ovid Therapeutics Inc (NASDAQ: OVID) with an Outperform rating and $14.48 price target. It's Time To Tackle Orphan Neurological Disorders Until now, the biopharmaceutical industry has mostly ignored orphan neurological disorders due to the difficulty of...
-
Analyst: Kite Pharma's CAR-T Patient Death, Stock Selloff Is A Buying Opportunity
Monday, May 8, 2017 - 11:31am | 368Read More...For a biopharmaceutical company, there may be no worse news than the death of a patient receiving treatment during clinical testing. On Monday, shares of Kite Pharma Inc (NASDAQ: KITE) plummeted more than 12 percent after the company disclosed that a patient with brain cancer died following...
-
How Walt Mossberg Changed The Way We Think About Apple, Google And Others
Monday, April 10, 2017 - 8:26am | 961Read More...Walt Mossberg, a name synonymous with tech reporting, has decided to hang up his boots after a career spanning over 47 years. He made a name as a make-or-break reviewer of technology products, to whom many people looked before finalizing tech purchase decisions. Booting Into A Journalistic Career...
-
Should Alphabet's Larry Page Build A Relationship With President-Elect Trump?
Wednesday, January 18, 2017 - 4:26pm | 345Read More...Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL)'s co-founder and CEO Larry Page needs to build a close relationship with President-elect Donald Trump, at least according to Adam Zuckerman, the founder of Fosterly. Speaking to CNBC, Zuckerman argued that Alphabet is one of the largest companies in the...
-
Who Is Alex Karp And Why Was He Given A Seat At Trump's Tech Summit Table?
Thursday, December 15, 2016 - 4:00pm | 393Read More...President-elect Donald Trump hosted some of the top technology leaders for a summit, and the guest list was a typical "who's who" of Silicon Valley with one exception. Names such as Apple Inc. (NASDAQ: AAPL)'s CEO Tim Cook, Amazon.com, Inc. (NASDAQ: AMZN)'s CEO Jeff Bezos, Alphabet Inc (NASDAQ:...
-
Alphabet Takes A Cue From Twitter, Moves Toward Diversifying Board
Thursday, June 30, 2016 - 3:20pm | 285Read More...Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) took a leaf out of Twitter Inc (NYSE: TWTR)'s playbook as it appointed its first African-American board member, naming Roger Ferguson, Jr. to its board of directors. A CNN Money report said Twitter appointed its first African-American board member, Debra...
-
Cowen Downgrades Ionis After Thrombocytopenia Issues
Thursday, May 26, 2016 - 1:33pm | 286Read More...Ionis Pharmaceuticals Inc (NASDAQ: IONS) shares are tanking nearly 40 percent on Thursday following the company’s disclosure that severe cases of thrombocytopenia have been associated with two of its major drug programs: TTR in FAP and APOC3 in FCS. Cowen & Co analyst Eric Schmidt has...
-
'The Coach' Of Silicon Valley Passes Away
Monday, April 18, 2016 - 2:25pm | 347Read More...Bill Campbell, a major figure in shaping Silicon Valley, died on Monday. Campbell is perhaps best known for his work at Apple Inc. (NASDAQ: AAPL). He joined the company in 1983 as vice president of marketing and served as a member of the Board of Directors from 1997 to 2014 following brief...
-
Cowen Analysts Happy About Relypsa-Veltassa Launch, Say These Four Things Are Coming
Tuesday, January 26, 2016 - 10:31am | 381Read More...The share price of Relypsa Inc (NASDAQ: RLYP) has declined 32.09 percent over the past one month, following a 42.17 percent appreciation over the past three months. Cowen’s Eric Schmidt has maintained an Outperform rating on the company. Data from the drug-drug interaction study for...
-
Disappointing Drug News Sends Biogen And XOMA Shares Down
Wednesday, July 22, 2015 - 10:34am | 560Read More...Shares of Biogen Inc (NASDAQ: BIIB) were trading lower by more than 3 percent Wednesday morning after the company reported mixed results in a Phase 1 Alzheimer's study in which a 6MG dose failed to significantly slow mental decline. "We are encouraged by these new results, which...
-
Stifel, JMP Securities Discuss What To Expect From AAIC Conference
Monday, July 20, 2015 - 8:30am | 464Read More...In a report published Monday, JMP Securities analyst Michael King discussed the potential upside for the biotech sector ahead of the upcoming Alzheimer's Association International Conference (AAIC) that will take place July 18 through July 23 in Washington, D.C. King noted various media...













